TARGETING CD24-SIGLEC INTERACTIONS FOR THE TREATMENT AND PREVENTION OF NONALCOHOLIC… Application EP-3921338-A4 European Patent Office 23 Nov 2022
MONOCLONAL ANTIBODIES AGAINST HUMAN SIGLEC-9 AND USE THEREOF FOR IMMUNOTHERAPY Application WO-2021247821-A1 World Intellectual Property Organisation (WIPO) 09 Dec 2021
ANTI-SIGLEC-9 ANTIBODY MOLECULES Application WO-2021094545-A1 World Intellectual Property Organisation (WIPO) 20 May 2021